Pertussis hospitalizations among infants in the United States, 1993 to 2004
Related Experiment Video
Updated: Jul 7, 2026

Evaluation of Host-Pathogen Responses and Vaccine Efficacy in Mice
Published on: February 22, 2019
Margaret M Cortese1, Andrew L Baughman, Rongping Zhang
1National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia 30333, USA. mcortese@cdc.gov
Insights
Infant pertussis hospitalization rates were stable from 1993-2004, with the highest incidence in 1-2 month olds. Discharge databases revealed higher pertussis rates than passive surveillance, highlighting the need for early infant protection.
Area of Science:
- Pediatrics
- Infectious Diseases
- Public Health Surveillance
Background:
- Pertussis (whooping cough) poses a significant risk to infants, necessitating accurate incidence data.
- Passive national surveillance systems may underestimate the true burden of infant pertussis hospitalizations.
- Utilizing hospitalization discharge databases offers a more robust method for tracking disease incidence.
Purpose of the Study:
- To determine infant pertussis hospitalization rates using non-passive reporting databases.
- To compare these rates with those from the traditional passive national surveillance system.
- To analyze pertussis complications and procedures in hospitalized infants.
Main Methods:
- Analysis of two national hospitalization discharge databases (Nationwide Inpatient Sample and Kids' Inpatient Database) from 1993-2004.
- Comparison with data from the National Notifiable Disease Surveillance System/Supplemental Pertussis Surveillance System.
- Stratification of rates by age groups within infants (< 1 year) and examination of complications.
Main Results:
- Pertussis hospitalization rates for infants < 2 months remained stable between 1993-2004.
- Discharge databases showed approximately double the incidence of pertussis hospitalizations compared to passive reporting.
- Infants aged 1-2 months had the highest incidence; 86% of hospitalizations occurred in infants ≤ 3 months, who also accounted for most mechanical ventilation and deaths.
Conclusions:
- Infant pertussis hospitalization incidence was stable from 1993-2004, peaking in the 1-2 month age group.
- Hospitalization databases provide a more accurate measure of pertussis burden in young infants.
- Monitoring the impact of adolescent/adult Tdap vaccination on infant pertussis is crucial, and strategies for early infant protection should be prioritized.
Objective:
We sought to describe the rates of pertussis hospitalization among infants by using databases that do not rely on passive reporting and compare with results obtained from the passive national surveillance system.
Methods:
The incidence of infant pertussis hospitalization in 1993 to 2004 was determined by using 2 national hospitalization discharge databases (Nationwide Inpatient Sample and Kids' Inpatient Database) and the National Notifiable Disease Surveillance System/Supplemental Pertussis Surveillance System. Rates were determined for separate age groups among infants < 1 year of age. Pertussis complications and procedures were examined by using the Kids' Inpatient Database.
Results:
In 1993 to 2004, the pertussis hospitalization rates for infants < or = 2 months of age were generally stable, by the discharge databases. The incidence of infant pertussis hospitalization obtained from the Nationwide Inpatient Sample and Kids' Inpatient Database was approximately 2 times greater than that obtained from the passive reporting system. Infants 1 to 2 months of age had the highest incidence (239 hospitalizations per 100,000 live births in the 2003 Kids' Inpatient Database). An annual average of 2678 hospitalizations occurred in 2000 and 2003; 86% occurred in infants < or = 3 months of age. Among those with ages provided, 95% of infants who required mechanical ventilation and all of those who died were < or = 3 months of age.
Conclusions:
Pertussis hospitalization incidence rates among the youngest infants were generally stable in 1993 to 2004 and were highest for infants 1 to 2 months of age. The impact of the new adolescent and adult tetanus-diphtheria-acellular pertussis vaccines on infant pertussis should be monitored through such discharge databases. Additional vaccination strategies should be evaluated to protect infants as early in life as possible.
Related Concept Videos
Vaccinations
Pneumonia I: Introduction
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Pneumonia I: Introduction
Pulmonary Tuberculosis V
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the progression...
Pulmonary Tuberculosis I
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Transmission-based Precautions II: Airborne and Protective Environment
Airborne precautions:
Use airborne precautions when treating patients known or suspected to have diseases that spread through the air—for example, tuberculosis or measles. These organisms are present in smaller droplets expelled by an infected person and...
